Effective treatment is yet to be found; although in T2DM and obesity, adiponectin was reported to be a cardioprotective adipokine that is downregulated, adiponectin signaling is also impaired due to the downregulation of both receptors (AdipoR1 and R2), leading to reducing cardio protection. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.